Treatment strategies for hepatocellular carcinoma (HCC): Now it’s personal(ized)
Cost: FreeView Offer chevron_right
Activity Description / Statement of Need:
In this online, self-learning activity:
Cancer of the liver is one of the leading causes of cancer-related deaths and one of the more common types of cancer worldwide, with an incidence of over 40,000 in the U.S. and an annual mortality rate of over 30,000 new cases each year. Of all the primary liver cancers, hepatocellular carcinoma (HCC) is the most common form, representing 80%, and its incidence has risen threefold in the U.S. over the past 40 years. The largest risk factor is cirrhosis due to chronic hepatitis B or C viruses, and additional risk factors include excess alcohol consumption, diabetes, non-alcoholic fatty liver disease, and smoking. HCC is diagnosed in the intermediate or advanced stages of disease the vast majority of the time and carries a grave prognosis with a five-year survival rate of eighteen percent.
This learning activity has been designed to bring HCPs’ knowledge of optimal, personalized strategies for the management of advanced / unresectable HCC and to improve their competence and performance in treating it.
The following healthcare professionals: Medical oncologists, hepatologists, physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with advanced / unresectable HCC.